Anchiano Therapeutics

$1.03
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-21.62%) Today
-$0.13 (-11.21%) As of 8:48 AM EDT after-hours

Why Robinhood?

You can buy or sell ANCN and other stocks, options, and ETFs commission-free!

About ANCN

Anchiano Therapeutics Ltd. American Depositary Share, also called Anchiano Therapeutics, is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Read More Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. The listed name for ANCN is Anchiano Therapeutics Ltd. American Depositary Share.

Employees
16
Headquarters
Jerusalem, Jerusalem
Founded
2004
Market Cap
8.61M
Price-Earnings Ratio
Dividend Yield
Average Volume
1.52M
High Today
$1.39
Low Today
$1.10
Open Price
$1.38
Volume
904.92K
52 Week High
$2.51
52 Week Low
$0.5136

Collections

ANCN Earnings

-$0.70
-$0.47
-$0.23
$0.00
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
per share
Actual
Expected Nov 12

You May Also Like